Samyang Group

Pharmaceutical Business

  • Samyang Biopharm

    Samyang Biopharm endeavors to develop diverse drugs based on its drug delivery system technology, and to utilize biodegradable polymers and develop diverse medical devices. By doing so, we aim to become an innovative specialty pharmaceutical company that promotes good human health and that helps enrich the quality of human life.

    Details
  • Samyang Research Center

    SRC introduces technologies from drug/bio-related companies in the U.S., and conducts joint research with them in a bid to secure promising technologies. It exports Samyang Biopharm's original DDS technology, supporting the latter's globalization strategies.

    Details
  • Medichem

    In 2017, Samyang Biopharm acquired Medichem Co., Ltd., which possesses the technology and manufacturing facilities to synthesize crude chemical materials, in order to increase the competitiveness of our biodegradable suture. Currently, Medichem is producing biodegradable monomers, Glycolide, Lactide, and pDO, for the domestic and overseas markets. Moreover, Medichem also possesses the technology and manufacturing facilities to synthesize crude chemical materials used for electricity and electronics, automobile engineering plastic, and so on. Based on such advantages, Medichem is expected to amplify the synergy with Samyang Corporation’s biodegradable suture and engineering plastic business.